Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant health issue worldwide, particularly in developing nations. This article aims to provide an updated approach to its diagnosis and treatment, based on recent research and advancements.
Early diagnosis of enteric fever is crucial for effective management. Traditionally, blood culture has been the gold standard for diagnosis. However, its sensitivity is not optimal, especially in early disease stages or after antibiotic therapy. Recent advancements include nucleic acid amplification tests (NAATs), which have shown promising results in terms of sensitivity and specificity. Moreover, serological tests like Typhidot and Tubex have improved, although their reliability varies across different populations.
Treatment of enteric fever mainly involves antibiotic therapy. The choice of antibiotics has evolved due to increasing antibiotic resistance. Fluoroquinolones, once the first-line treatment, have seen decreased efficacy due to widespread resistance. Current guidelines recommend third-generation cephalosporins like ceftriaxone or cefixime, or azithromycin as first-line treatment. However, the choice should be guided by local susceptibility patterns. Moreover, supportive care including hydration and fever control is vital.
Prevention plays a key role in managing enteric fever. This includes provision of safe drinking water, improved sanitation, and vaccination. Two vaccines, Vi polysaccharide vaccine and Ty21a, are currently available. However, their use is recommended in high-risk areas or for travelers to such areas, as their efficacy is not 100%.
Enteric fever continues to pose a significant health challenge, especially in resource-limited settings. Early diagnosis and appropriate treatment are essential for patient recovery. The emergence of antibiotic resistance necessitates continuous surveillance and updating of treatment guidelines. Preventive strategies, including vaccination and improvements in water and sanitation, are equally important in controlling the disease.
1.
Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.
2.
Childhood cancer survivors face new health problems later in life, study shows
3.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
4.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
5.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
1.
Obesity is a major risk factor for cancer
2.
Prevention of Thrombotic Complications in High-Risk Patients
3.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
4.
Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Hands-on Workshop: Hematology
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation